{"id":520797,"date":"2021-07-30T09:34:08","date_gmt":"2021-07-30T13:34:08","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/"},"modified":"2021-07-30T09:34:08","modified_gmt":"2021-07-30T13:34:08","slug":"thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/","title":{"rendered":"Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer?"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">NEW YORK<\/span>, <span class=\"xn-chron\">July 30, 2021<\/span> \/PRNewswire\/ &#8212;\u00a0InvestorsObserver issues critical PriceWatch Alerts for TEAM, CRSP, QGEN, AAPL, and PFE.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.html\" target=\"_blank\" rel=\"nofollow noopener\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg\" title=\"InvestorsObserver (PRNewsfoto\/InvestorsObserver)\" alt=\"InvestorsObserver (PRNewsfoto\/InvestorsObserver)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Click a link below then choose between in-depth options trade idea report or a stock score report.<\/p>\n<p>Options Report \u2013 Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.<\/p>\n<p>Stock Report &#8211; Measures a stock&#8217;s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street&#8217;s opinion including a 12-month price forecast.<\/p>\n<ul type=\"disc\">\n<li>TEAM: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3244766-2&amp;h=1338528790&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DTEAM%26prnumber%3D073020214&amp;a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DTEAM%26prnumber%3D073020214\" rel=\"nofollow noopener\">https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=TEAM&amp;prnumber=073020214<\/a><\/li>\n<li>CRSP: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3244766-2&amp;h=1004688092&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DCRSP%26prnumber%3D073020214&amp;a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DCRSP%26prnumber%3D073020214\" rel=\"nofollow noopener\">https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=CRSP&amp;prnumber=073020214<\/a><\/li>\n<li>QGEN: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3244766-2&amp;h=42469499&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DQGEN%26prnumber%3D073020214&amp;a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DQGEN%26prnumber%3D073020214\" rel=\"nofollow noopener\">https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=QGEN&amp;prnumber=073020214<\/a><\/li>\n<li>AAPL: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3244766-2&amp;h=4127393387&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DAAPL%26prnumber%3D073020214&amp;a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DAAPL%26prnumber%3D073020214\" rel=\"nofollow noopener\">https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=AAPL&amp;prnumber=073020214<\/a><\/li>\n<li>PFE: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3244766-2&amp;h=2079066518&amp;u=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DPFE%26prnumber%3D073020214&amp;a=https%3A%2F%2Fwww.investorsobserver.com%2Flp%2Fpr-options-lp-2%2F%3Fstocksymbol%3DPFE%26prnumber%3D073020214\" rel=\"nofollow noopener\">https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=PFE&amp;prnumber=073020214<\/a><\/li>\n<\/ul>\n<p>(Note: You may have to copy this link into your browser then press the [ENTER] key.)<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CG60181&amp;sd=2021-07-30\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer-301345127.html\">https:\/\/www.prnewswire.com\/news-releases\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer-301345127.html<\/a><\/p>\n<p>SOURCE  InvestorsObserver<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=CG60181&amp;Transmission_Id=202107300931PR_NEWS_USPR_____CG60181&amp;DateId=20210730\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK, July 30, 2021 \/PRNewswire\/ &#8212;\u00a0InvestorsObserver issues critical PriceWatch Alerts for TEAM, CRSP, QGEN, AAPL, and PFE. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report \u2013 Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock. Stock Report &#8211; Measures a stock&#8217;s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street&#8217;s opinion including a 12-month price forecast. TEAM: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=TEAM&amp;prnumber=073020214 CRSP: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=CRSP&amp;prnumber=073020214 QGEN: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=QGEN&amp;prnumber=073020214 AAPL: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=AAPL&amp;prnumber=073020214 PFE: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=PFE&amp;prnumber=073020214 (Note: You may have to copy this link into your browser then press the [ENTER] key.) &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer?&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-520797","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer? - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer? - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK, July 30, 2021 \/PRNewswire\/ &#8212;\u00a0InvestorsObserver issues critical PriceWatch Alerts for TEAM, CRSP, QGEN, AAPL, and PFE. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report \u2013 Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock. Stock Report &#8211; Measures a stock&#8217;s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street&#8217;s opinion including a 12-month price forecast. TEAM: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=TEAM&amp;prnumber=073020214 CRSP: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=CRSP&amp;prnumber=073020214 QGEN: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=QGEN&amp;prnumber=073020214 AAPL: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=AAPL&amp;prnumber=073020214 PFE: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=PFE&amp;prnumber=073020214 (Note: You may have to copy this link into your browser then press the [ENTER] key.) &hellip; Continue reading &quot;Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer?&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-30T13:34:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer?\",\"datePublished\":\"2021-07-30T13:34:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\\\/\"},\"wordCount\":192,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1333368\\\/InvestorsObserver_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\\\/\",\"name\":\"Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer? - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1333368\\\/InvestorsObserver_Logo.jpg\",\"datePublished\":\"2021-07-30T13:34:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1333368\\\/InvestorsObserver_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1333368\\\/InvestorsObserver_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer? - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/","og_locale":"en_US","og_type":"article","og_title":"Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer? - Market Newsdesk","og_description":"PR Newswire NEW YORK, July 30, 2021 \/PRNewswire\/ &#8212;\u00a0InvestorsObserver issues critical PriceWatch Alerts for TEAM, CRSP, QGEN, AAPL, and PFE. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report \u2013 Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock. Stock Report &#8211; Measures a stock&#8217;s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street&#8217;s opinion including a 12-month price forecast. TEAM: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=TEAM&amp;prnumber=073020214 CRSP: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=CRSP&amp;prnumber=073020214 QGEN: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=QGEN&amp;prnumber=073020214 AAPL: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=AAPL&amp;prnumber=073020214 PFE: https:\/\/www.investorsobserver.com\/lp\/pr-options-lp-2\/?stocksymbol=PFE&amp;prnumber=073020214 (Note: You may have to copy this link into your browser then press the [ENTER] key.) &hellip; Continue reading \"Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer?\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-30T13:34:08+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer?","datePublished":"2021-07-30T13:34:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/"},"wordCount":192,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/","name":"Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer? - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg","datePublished":"2021-07-30T13:34:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1333368\/InvestorsObserver_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/thinking-about-trading-options-or-stock-in-atlassian-crispr-therapeutics-qiagen-apple-or-pfizer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Thinking about trading options or stock in Atlassian, Crispr Therapeutics, Qiagen, Apple, or Pfizer?"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/520797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=520797"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/520797\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=520797"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=520797"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=520797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}